SCHEMBL6811380

SCHEMBL6811380

CC1CN(c2ccc(F)c3cc(F)ccc23)CCN1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.44
ALDH1A1 P00352 3/20 0.43
LMNA P02545 1/20 0.43
HSD11B1 P28845 1/20 0.41
XIAP P98170 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HTT P42858 1/20 0.39
KHK P50053 2/20 0.38
ACVR1 Q04771 1/20 0.37
MAPT P10636 2/20 0.36
KDR P35968 1/20 0.36
CTNNB1 P35222 2/20 0.35
TCF7L2 Q9NQB0 2/20 0.35
USP28 Q96RU2 2/20 0.35
USP25 Q9UHP3 1/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CSNK1E P49674 1/20 0.35
KIT P10721 1/20 0.35
PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811374 1.00 HTR2C (0.44) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL6808586 0.87 ALDH1A1 (0.44) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL6808590 0.87 ALDH1A1 (0.44) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL5631645 0.84 XIAP (0.45) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL5631643 0.84 XIAP (0.45) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL14922244 0.84 ALDH1A1 (0.48) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL6811515 0.84 HTR2C (0.41) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL21358968 0.80 LMNA (0.47) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL21358964 0.80 LMNA (0.47) HTR2CALDH1A1LMNAHSD11B1XIAP
SCHEMBL21358963 0.80 LMNA (0.47) HTR2CALDH1A1LMNAHSD11B1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040122001-A1 Pharmaceutical compounds ELI LILLY AND COMPANY 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122001-A1 Pharmaceutical compounds CYP2D6, LPXN, CYP1B1 HTR2C 1211/4885ALDH1A1 1563/4885LMNA 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.